{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-004450","form_type":"8-K","ticker":"RBOT","cik":"0001812173","company_name":"Vicarious Surgical Inc.","filed_at":"2023-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.697138+00:00","generated_at":"2026-06-20T11:56:51.710045+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Vicarious Surgical appoints Victoria Carr-Brendel to board; Phil Liang resigns","bullets":["Victoria Carr-Brendel, Ph.D., appointed to board effective Jan 23, 2023; deemed independent under NYSE rules.","Carr-Brendel is Group VP of Cochlear Implants at Sonova Group and President of Advanced Bionics.","She previously served as CEO of JenaValve and held roles at Boston Scientific (NYSE:BSX).","Philip Liang resigned from board effective Jan 23, 2023; not due to any disagreement with the company.","Standard nonemployee director compensation and indemnification agreement apply to Carr-Brendel."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-004450","json":"https://secwatch.observer/filing/0001213900-23-004450.json","markdown":"https://secwatch.observer/filing/0001213900-23-004450.md","text":"https://secwatch.observer/filing/0001213900-23-004450.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1812173/000121390023004450/0001213900-23-004450-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1812173/000121390023004450/ea172024-8k_vicarious.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T11:56:51.710045+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5a48dc9f0e","claim":"Philip Liang resigned as Director at Vicarious Surgical Inc..","evidence_excerpt":"Philip Liang, a member of the Board, notified the Company that he is resigning from the Board, effective as of January 23, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390023004450/0001213900-23-004450-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"d754315393","claim":"Victoria Carr-Brendel was appointed as Director at Vicarious Surgical Inc..","evidence_excerpt":"appointed Victoria Carr-Brendel, Ph.D. to the Board, effective as of January 23, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1812173/000121390023004450/0001213900-23-004450-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}